✦ LIBER ✦

Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)

✍ Scribed by Wiernik, P H; Paietta, E; Goloubeva, O; Lee, S J; Makower, D; Bennett, J M; Wade, J L; Ghosh, C; Kaminer, L S; Pizzolo, J

Book ID: 110056017
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 113 KB
Volume: 18
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403494

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of carboplatin in blast c

Phase II study of carboplatin in blast crisis of chronic myeloid leukemia: Eastern Cooperative Oncology Group Study E1992

✍ Dutcher, J P; Lee, S; Paietta, E; Bennett, J M; Stewart, J A; Wiernik, P H 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

Docetaxel for Malignant Mesothelioma: Ph

Docetaxel for Malignant Mesothelioma: Phase II Study of the Eastern Cooperative Oncology Group

✍ Chandra P. Belani; Sudeshna Adak; Seena Aisner; Philip J. Stella; Nathan Levitan 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 146 KB

Modified vincristine, doxorubicin, and d

Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia an eastern cooperative oncology group study

✍ William R. Friedenberg; Janet Anderson; Barbara C. Wolf; Peter A. Cassileth; Mar 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

Phase II Study of Interferon Gamma in Ma

Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group

✍ Keith Stuart; Donna E. Levy; Tom Anderson; Constantine A. Axiotis; Janice P. Dut 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 82 KB

Phase II study of α2 interferon in the t

Phase II study of α2 interferon in the treatment of the chronic myeloproliferative disorders (E5487) : A trial of the Eastern Cooperative Oncology Group

✍ Arthur I. Radin; Haesook T. Kim; Barbara W. Grant; John M. Bennett; John M. Kirk 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND In vitro and clinical data suggest a therapeutic role for α2 interferon (IFN) in the treatment of the chronic myeloproliferative disorders. Accordingly, a multiinstitutional, Phase II trial of IFN in patients with agnogenic myeloid metaplasia (AMM), essential thrombocythe

Phase II trial of 2-chlorodeoxyadenosine

Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: A study of the Eastern Cooperative Oncology Group (ECOG), E5995

✍ Michael S Gordon; Molly L Young; Martin S Tallman; Larry D Cripe; John M Bennett 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 70 KB